Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trial

SARS-CoV-2 anti-spike protein IgG concentration, ELU/mL Day 28 after the third dose 23,325 (20,030–27,162); 66 25,317 (20,996–30,528); 66 20,502 (16,473–25,517); 35 21,980 (16,476–29,324); 33 26,982 (22,056–33,008); 31 29,161 (23,093–36,823); 33 Day 0 of fourth dose 3049 (2550–3646); 66 3469 (2730–4407); 66 2532 (1974–3247); 35 2571 (1874–3527); 34 3761 (2959–4780); 31 4769 (3421–6648); 32 Day 14 … Read more

2 Mass. pediatric hepatitis cases under investigation, DPH says

The Massachusetts Department of Public Health is investigating two cases of pediatric hepatitis in the state, but both cases have tested negative for adenovirus infection.The DPH said no additional details are being released to respect the privacy of the pediatric patients. Last week, the US Centers for Disease Control and Prevention said that it investigating … Read more

Hawaii reports mysterious hepatitis in child under 10 years old

Hawaii has become the 25th state to begin probing a case of mysterious hepatitis in a child less than ten years old — after five deaths and more than 100 cases were reported across America. The state’s Department of Health said the child was hospitalized with abdominal pain and fever on Maui, its second largest … Read more

Bharat Biotech To Get $19 Million For Development Of ‘Variant Proof’ Covid Vaccine

CEPI will fund the initiative under its USD 200 million program to advance the development of vaccines New Delhi: The Coalition for Epidemic Preparedness Innovations (CEPI) on Tuesday said it will provide up to USD 19.3 million (about Rs 149 crore) to Bharat Biotech International, the University of Sydney, and Switzerland-based ExcellGene SA for the … Read more